HLB Panagene Co., Ltd. (KOSDAQ:046210)
South Korea · Delayed Price · Currency is KRW 1,790.00
-78.00 (-4.18%)
At close: Jan 29, 2026
HLB Panagene Market Cap
HLB Panagene has a market cap or net worth of 81.39 billion as of January 30, 2026. Its market cap has decreased by -32.81% in one year.
Market Cap
81.39B
Enterprise Value
55.49B
Revenue
14.29B
Ranking
n/a
PE Ratio
48.72
Stock Price
1,790.00
Market Cap Chart
Since August 29, 2001, HLB Panagene's market cap has increased from 17.29B to 81.39B, an increase of 370.75%. That is a compound annual growth rate of 6.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 81.39B | 3.11% |
| Dec 30, 2025 | 78.94B | -34.15% |
| Dec 30, 2024 | 119.87B | -29.22% |
| Dec 28, 2023 | 169.35B | 24.28% |
| Dec 29, 2022 | 136.26B | 11.73% |
| Dec 30, 2021 | 121.96B | -11.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 474.83B |
| Dx & Vx | 320.88B |
| Cytogen | 179.94B |
| GENINUS | 136.41B |
| Green Cross Medical Science | 84.68B |
| Protia | 72.11B |
| Seoulin Bioscience | 59.58B |
| GeneMatrix | 49.45B |